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Prevalence of decreased kidney function in Chinese adults aged
35 to 74 years.
Background. Chronic kidney disease (CKD) is a major public
health burden in Western countries but little is known about its
impact in developing countries. We estimated the prevalence
and absolute burden of CKD in the general adult population in
China.
Methods. A cross-sectional survey was conducted in a na-
tionally representative sample of 15,540 Chinese adults aged 35
to 74 years in 2000 and 2001. Serum creatinine was measured
using the modified kinetic Jaffe reaction method at a central
laboratory calibrated to the Cleveland Clinic Foundation lab-
oratory. Glomerular filtration rate (GFR) was estimated using
the simplified equation developed by the Modification of Diet
in Renal Disease study. CKD was defined as an estimated GFR
<60 mL/min/1.73m2.
Results. Overall, the age-standardized prevalences of GFR
60 to 89, 30 to 59, and <30 mL/min/1.73m2 were 39.4%, 2.4%,
and 0.14%, respectively, in Chinese adults aged 35 to 74 years.
The overall prevalence of CKD (GFR <60 mL/min/1.73m2)
was 2.53%, representing 11,966,653 persons (1.31% or 3,185,330
men and 3.82% or 8,781,323 women). The age-specific preva-
lence of CKD was 0.71%, 1.69%, 3.91%, and 8.14% among
persons 35 to 44, 45 to 54, 55 to 64, and 65 to 74 years old, re-
spectively. The age-standardized prevalence of CKD was similar
in urban (2.60%) and rural (2.52%) residents but was higher in
south China (3.05%) than in north China (1.78%) residents.
Conclusion. Although the prevalence of CKD in China was
relatively low, the population absolute burden is substantial.
These data warrant a national program aimed at detection, pre-
vention, and treatment of CKD in China.
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Chronic kidney disease (CKD) is a major public health
burden in Western countries. For example, according
to data from the Third National Health and Nutri-
tion Examination Survey (NHANES III), 8.3 million
(4.6%) U.S. adults aged 20 years or older were estimated
to have an estimated glomerular filtration rate (GFR)
<60 mL/min/1.73m2. In addition, 5.9 million individuals
(3.3%) had persistent albuminuria with a normal GFR
and 5.3 million (3.0%) had persistent albuminuria with a
GFR 60 to 89 mL/min/1.73m2. Overall, the prevalence of
CKD was 11% (19.2 million) in the U.S. adult population
[1, 2]. CKD is an important risk factor for end-stage renal
disease (ESRD), cardiovascular disease, and premature
death [3–5]. Patients with ESRD have poorer quality of
life and shorter life expectancy compared to individuals of
the same age in the general population [3, 4]. In addition,
death from cardiovascular disease is 10 to 20 times higher
among patients treated by maintenance hemodialysis or
peritoneal dialysis than in the U.S. general population af-
ter controlling for age, gender, race, and presence of dia-
betes [5]. A number of prospective epidemiologic studies
have shown that individuals with CKD are at substan-
tially increased risk for coronary heart disease, stroke,
and congestive heart failure, independent of established
cardiovascular risk factors [6–12].
The burden of CKD and ESRD in economically devel-
oping countries, including China, is less well known. In
1999, the China Dialysis and Transplantation Registra-
tion Group reported a point prevalence and annual inci-
dence of ESRD of 33.2 and 15.3 per million population,
respectively [13]. These rates are likely to be underesti-
mated since the registration response rate was low, less
than 50% in most provinces [14]. The impact of ESRD in
China is of particular concern since there is a shortage of
healthcare resources to devote to this problem. For ex-
ample, about 16% of dialysis patients died from uremia
due to interruptions in their dialysis therapy, which were
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a result of personal financial hardships [13]. Moreover,
only about 30% of hemodialysis and peritoneal dialysis
patients received erythropoietin and the majority of dial-
ysis patients had various degrees of anemia [13]. Early
detection, prevention, and treatment of CKD are essen-
tial to any meaningful attempt to decrease the societal
and personal burden of ESRD in China. The objectives
of the present study were to estimate the prevalence and
severity of CKD in the general adult population in China
using serum creatinine–based equations to estimate level
of kidney function. The distribution of CKD was exam-
ined by age, gender, and geographic region, as well as in
rural versus urban areas. This information might be useful
for healthcare policy makers to develop national strate-
gies and to rationally plan health services for the preven-
tion and treatment of CKD and its related complications.
METHODS
Study population
The International Collaborative Study of Cardiovascu-
lar Disease in ASIA (InterASIA) was a cross-sectional
study of cardiovascular disease risk factors in a nationally
representative sample of the general adult population in
China [15]. A four-stage stratified sampling method was
used. In stage one, 31 provinces (and municipalities) were
stratified into northern and southern China, as divided
by the Yangtzi River. In addition to the municipalities
of Beijing in northern China and Shanghai in southern
China, four provinces from northern China (Jilin, Shan-
dong, Qinghai, and Shanxi) and four from southern China
(Sichuan, Hubei, Fujian, and Guangxi) were selected to
be representative of the geographic and economic char-
acteristics in their regions (Fig. 1). In the second stage
of sampling, one rural county and one city region were
randomly selected from each province or municipality,
providing a total of 10 city regions and 10 rural counties.
In the third stage of sampling, one township or one street
district (about 1000–2000 households) was randomly se-
lected from each of the counties and city regions, respec-
tively. In the final stage, individuals were randomly cho-
sen from the selected township or street district. Only
one participant was selected from each household, with-
out replacement.
A total of 19,012 persons aged 35 to 74 years were ran-
domly selected from 20 primary sampling units (street
districts in urban areas or townships in rural areas) and
invited to participate. A total of 15,838 persons (7684 men
and 8154 women) completed the survey and examination.
The overall response rate was 83.3% (82.1% in men and
84.5% in women; 82.2% in urban areas and 84.4% in rural
areas). The analysis reported in this paper was restricted
to study participants (N = 15,209) who had serum crea-
tinine measurements.
The Institutional Review Board at the Tulane Uni-
versity Health Sciences Center approved the InterASIA
study. In addition, ethics committees and other relevant
regulatory bodies in China approved the study. Informed
consent was obtained from each study participant prior to
data collection. Study participants with untreated med-
ical conditions or elevated cholesterol or glucose levels
identified during the examination were referred to a pri-
mary health care provider.
Data collection
Data were collected in examination centers at local
health stations or community clinics in the participants’
residential area. During the visits, trained research staff
administered a standard questionnaire to obtain informa-
tion on demographic characteristics, including age, sex,
education, occupation, and annual household income.
During the clinical examination, blood pressure and an-
thropometric measurements were collected by trained
and certified physicians or nurses using standard proto-
cols and techniques [16]. Blood pressure was measured
three times with the participant in the seated position
after five minutes of rest. Body weight and height were
measured twice during the examination in light indoor
clothing without shoes.
Overnight fasting blood specimens were collected for
measurement of serum creatinine, lipids, and glucose.
Blood specimens were processed at each field center and
shipped by air to the central clinical laboratory at the De-
partment of Population Genetics at Fuwai Hospital of the
Chinese Academy of Medical Sciences in Beijing, where
the specimens were stored at −70◦C until laboratory as-
says could be performed. Serum creatinine was measured
by the modified kinetic Jaffe reaction on a Hitachi 7060
Clinical Analyzer (Hitachi High-Technologies Corpora-
tion, Tokyo, Japan) using commercial reagents and re-
ported using conventional units (1 mg/dL = 88.4 lmol/L).
In addition, a random sample of 60 serum specimens was
sent to the Cleveland Clinic Laboratory (Cleveland, OH,
USA) for measurement of serum creatinine where the
Modification of Diet in Renal Disease (MDRD) Study
measured serum creatinine levels [17]. On average, serum
creatinine assays on the same samples were 0.0338 mg/dL
higher in the Cleveland Clinic Laboratory than in the In-
terASIA Study laboratory. Therefore, serum creatinine
measurements among study participants were calibrated
by adding this difference.
Statistical methods
The glomerular filtration rate (GFR) was estimated
from the simplified equation developed using MDRD
data [17]:
Estimated GFR = 186.3 × (serum creatinine)−1.154
× age−0.203 × (0.742 for women)
× (1.212 if African American).
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Fig. 1. A map of China with study sites (north China: Jilin, Beijing, Qinghai, Shanxi, and Shandong; south China: Sichuan, Hubei, Shanghai, Fujian,
and Guangxi).
In addition, the Cockcroft-Gault formula was used to
estimate creatinine clearance (CCr) from the serum cre-
atinine level [18]:
Cockcroft-Gault CCr = (140−age)/(serum creatinine)
× (weight/72)×(0.85 for women)
× body surface area
(BSA)/1.73m2
BSA was estimated using the following formula for
Chinese adults [19]:
BSA(m2) = 0.0061 × height (cm)
+ 0.0124 × weight kg) − 0.0099
Estimated GFR was analyzed as both a continuous
variable and a categorical variable with the follow-
ing four categories: GFR ≥90 mL/min/1.73m2, GFR 60
to 89 mL/min/1.73m2, GFR 30 to 59 mL/min/1.73m2,
and GFR <30 mL/min/1.73m2 [1]. The prevalence of
chronic kidney disease, defined as an estimated GFR
<60 mL/min/1.73m2 measured by the MDRD Study and
Cockcroft-Gault equations, was estimated overall, as well
as by sex, age group, geographic region, and urban ver-
sus rural residence. In addition, the distribution of serum
creatinine values was calculated for each gender and es-
timated GFR category.
Hypertension was defined as a mean systolic blood
pressure ≥140 mm Hg and/or diastolic blood pressure
≥90 mm Hg and/or use of antihypertensive medica-
tion. Diabetes was defined as fasting plasma glucose
≥7.0 mmol/L or a self-reported history of diabetes and
insulin or oral hypoglycemic treatment.
All calculations were weighted to represent the total
Chinese adult population aged 35 to 74 years. Sample
weights were calculated based on data from the year 2000
China Population Census and the InterASIA sampling
scheme, and took into account several features of the
survey, including oversampling for specific age or geo-
graphic subgroups, nonresponse, and other demographic
or geographic differences between the sample and the
total population. Standard errors were calculated by a
technique appropriate to the complex survey design. All
data analyses were conducted using SUDAAN (version
8.0; Research Triangle Institute, Research Triangle Park,
NC, USA).
RESULTS
The distribution of serum creatinine levels was slightly
skewed toward greater values in both men and women
(Fig. 2, upper panel). The estimated GFR values using
the simplified MDRD Study equation, however, were
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Fig. 2. Distribution of calibrated serum cre-
atinine levels (upper panel) and estimated
glomerular filtration rate (lower panel) in the
general adult population aged 35 to 74 years in
China, 2000 to 2001. GFR (mL/min/1.73m2)
was estimated using the simplified MDRD
Study equation.
normally distributed (Fig. 2, lower panel). The distri-
bution of serum creatinine levels was shifted toward
lower values in women than that in men, and the dis-
tribution of estimated GFR using the simplified MDRD
Study equation was also shifted toward lower values
in women than in men. Figure 3 shows that successive
categories of kidney function (GFR ≥90, 60–89, 30–
59, and <30 mL/min/1.73m2) estimated by the simpli-
fied MDRD Study equation corresponded to increasingly
greater serum creatinine values. The kidney function cat-
egories overlapped at the same levels of serum creatinine,
indicating the limitations of using serum creatinine level
and sex alone to estimate kidney function.
The age-standardized and age-specific prevalence of
normal and decreased kidney function (GFR categories)
estimated using the simplified MDRD Study equation
according to demographic characteristics is displayed in
Table 1. Overall, the age-standardized prevalences of
GFR 60 to 89, 30 to 59, and <30 mL/min/1.73m2 were
39.4%, 2.4%, and 0.14%, respectively, in Chinese adults
aged 35 to 74 years. The age-standardized prevalences of
mildly and moderately decreased kidney function were
greater in women than in men, while age-standardized
prevalence of severe decreased kidney function was sim-
ilar in men and women. Older age was associated with
greater prevalences of mildly, moderately, and severely
decreased kidney function. The age-standardized preva-
lences of mildly and severely decreased kidney function
were higher in urban residents than in rural residents,
while the age-standardized prevalence of moderately de-
creased kidney function was similar between urban and
rural residents. The age-standardized prevalence of de-
creased kidney function was higher in residents living in
south China than those in north China.
The prevalence of moderately and severely decreased
kidney function estimated using the Cockcroft-Gault
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Table 1. Age-standardized and age-specific prevalence of normal and
decreased kidney Function (GFR categories) by demographic
characteristics in China, 2000 to 2001
Prevalence of GFR category (mL/min/1.73m2)
≥90 60–89 30–59 <30
Percent (SE) Percent (SE) Percent (SE) Percent (SE)
Total 58.1 (0.5) 39.4 (0.5) 2.4 (0.2) 0.14 (0.04)a
Sex
Men 69.0 (0.6) 29.7 (0.6) 1.2 (0.2) 0.16 (0.06)a
Women 46.5 (0.7) 49.7 (0.7) 3.7 (0.3) 0.12 (0.06)b
Age years
35–44 71.9 (0.7) 27.4 (0.7) 0.7 (0.1) 0.02 (0.01)b
45–54 59.4 (1.0) 38.9 (0.9) 1.6 (0.2) 0.14 (0.09)b
55–64 45.7 (1.2) 50.4 (1.2) 3.8 (0.4) 0.11 (0.05)b
65–74 30.3 (1.5) 61.5 (1.6) 7.6 (0.8) 0.54 (0.24)a
Urbanization
Urban 47.4 (0.6) 50.0 (0.6) 2.4 (0.2) 0.24 (0.06)a
Rural 60.8 (0.6) 36.7 (0.6) 2.4 (0.2) 0.11 (0.05)b
Region
North 62.7 (0.7) 35.6 (0.7) 1.8 (0.2) 0.03 (0.02)b
South 54.8 (0.6) 42.2 (0.6) 2.8 (0.2) 0.21 (0.07)a
GFR (mL/min/1.73m2) estimated using the simplified MDRD study equation.
aEstimate is based on less than 30 individuals.
bEstimate is based on less than 10 individuals.
equation was much higher than the prevalence esti-
mated using the simplified MDRD Study equation in
the Chinese population. For example, the overall age-
standardized prevalence of GFR 60 to 89, 30 to 59, and
<30 mL/min/1.73m2 using the Cockroft-Gault formula
was 39.4%, 19.6%, and 0.8%, respectively. However, the
prevalence patterns of decreased kidney function esti-
mated using the Cockcroft-Gault equation were consis-
tent with those estimated using the simplified MDRD
Study equation according to sex, age, and other demo-
graphic characteristics (data not shown).
The overall age-standardized prevalence of CKD (de-
fined as GFR <60 mL/min/1.73m2) was 2.53% in the
Chinese adult population aged 35 to 74 years; represent-
ing 11,966,653 persons (Table 2). The age-standardized
prevalence of CKD was 1.31% (3,185,330 persons) in
men and 3.82% (8,781,323 persons) in women. The preva-
lence of CKD was higher with increased age in both men
and women. The age-standardized prevalence of CKD
was higher in persons with diabetes or hypertension com-
pared to those without. These associations were consis-
tent among all age groups (Fig. 4).
Age-standardized and age-specific calibrated serum
creatinine and estimated GFR levels by normal and de-
creased kidney function (estimated GFR categories) ac-
cording to demographic characteristics in the Chinese
adult population are shown in Table 3. The average cre-
atinine was 0.91 mg/dL among persons with a GFR 60
to 89 mL/min/1.73m2, 1.23 mg/dL among those with a
GFR 30 to 59 mL/min/1.73m2, and 2.86 mg/dL among
those with a GFR <30 mL/min/1.73m2. Women had sig-
nificantly lower mean creatinine levels compared to men
in the same ranges of GFR categories except for in the
severely decreased kidney function group. Mean creati-
nine levels were very similar among age groups within
each category of estimated GFR.
DISCUSSION
The worldwide burden of chronic kidney disease is cur-
rently unknown because there are only a few reports on
the prevalence from national representative samples, pri-
marily in Western countries. We contribute to this knowl-
edge by reporting the prevalence of CKD in the general
Chinese adult population aged 35 to 74 years. Our study
indicates that the prevalence of persons with an estimated
GFR <60 mL/min/1.73m2 is approximately 2.53%, which
represents approximately 12 million persons with CKD
in China.
To our knowledge, this study is the first in China and
possibly in any developing country to accurately report
the national burden of CKD. The strengths of this study
include a large representative sample of the Chinese adult
population, a high response rate, use of standardized pro-
tocols and data collection instruments, training of data
collectors, as well as ongoing quality assurance. To avoid
introducing bias during the estimation of GFR, serum
creatinine was measured at a central laboratory and cal-
ibrated according to Cleveland Clinic Laboratory stan-
dard, where the MDRD Study equation originated.
Our study had several limitations. First, GFR was not
directly measured in the study population. We used the
simplified MDRD Study equation and the Cockcroft-
Gault equation to estimate GFR. These equations might
over- or underestimate the actual GFR in the Chinese
population because these equations were developed pri-
marily in Caucasian populations in the U.S. Zuo et al
evaluated the validity of the simplified MDRD equation
and the Cockcroft-Gault equation on estimating kidney
function in 261 Chinese patients with CKD [20]. They
concluded that both equations overestimated GFR in pa-
tients with CKD stages 4 to 5 and underestimated GFR in
those with CKD stage 1. In addition, the Cockcroft-Gault
equation was more biased than the MDRD equation in
Chinese patients with CKD. There are several possible
reasons for this apparent discrepancy. Dual plasma sam-
pling of technetium Tc 99m-labeled diethylene triamine
pentaacetic acid plasma clearance was used to measure
GFR in the Chinese study, while renal clearance of iotha-
lamate was used in the MDRD study [17]. The dual blood
sampling method may overestimate GFR at lower levels
(by an average of 0.5 mL/min when GFR = 10 mL/min)
and underestimate GFR at higher levels (by an aver-
age of 20 mL/min when GFR = 100 mL/min) [21]. Fur-
thermore, plasma creatinine concentrations used in the
development of the MDRD equations were measured
by means of the kinetic alkalic picrate method (CX3
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Table 2. Age-standardized and age-specific prevalence of chronic kidney disease in the adult population aged 35 to 74 years in China, 2000 to 2001
Men Women Total
Age years Percent (SE) Estimated population (SE) Percent (SE) Estimated population (SE) Percent (SE) Estimated population (SE)
Total 1.31 (0.17) 3,185,330 (417,036) 3.82 (0.27) 8,781,323 (638,339) 2.53 (0.16) 11,966,653 (756,537)
35–44 0.24 (0.10) 228,676 (90,385)a 1.20 (0.24) 1,066,518 (210,444) 0.71 (0.12) 1,295,194 (228,878)
45–54 0.71 (0.23) 523,032 (168,215)a 2.74 (0.44) 1,906,839 (313,094) 1.69 (0.25) 2,429,871 (354,784)
55–64 1.60 (0.37) 715,815 (164,351) 6.40 (0.81) 2,653,792 (347,103) 3.91 (0.44) 3,369,606 (383,422)
65–74 5.80 (1.09) 1,717,807 (333,826) 10.43 (1.25) 3,154,174 (391,788) 8.14 (0.83) 4,871,981 (513,043)
Chronic kidney disease was defined as GFR <60 mL/min/1.73m2 estimated using the simplified MDRD study equation.
a Estimate is based on less than 30 individuals.
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Fig. 3. Joint distribution of calibrated serum
creatinine levels and estimated glomerular fil-
tration rate in the general adult population
aged 35 to 74 years in China, 2000 to 2001.
Within each serum creatinine level, the pro-
portion of individuals with normal and de-
creased kidney function (GFR categories) is
calculated using the simplified MDRD Study
equation.
Beckman method) and in the Chinese study by the al-
kalic picrate acid (Hitachi) method, which has been re-
ported to overestimate plasma creatinine concentrations
by approximately 8% [22]. The differences in the GFR
and plasma creatinine measurement methods might in-
troduce systematic error and cause inconsistency. In the
present study, we have recalibrated serum creatinine
levels based on the standard of the Cleveland Clinic
laboratory, where the MDRD equation was developed.
Furthermore, our findings on gender and age differences
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Table 3. Age-standardized and age-specific mean calibrated serum creatinine and GFR levels according to kidney function (GFR categories) by
demographic characteristics in China, 2000 to 2001
GFR category mL/min/1.73m2
≥90 60–89 30–59 <30 Total
Serum creatinine mg/dL Mean (SE)
Total 0.76 (0.00) 0.91 (0.00) 1.23 (0.02) 2.86 (0.10) 0.83 (0.00)
Sex
Men 0.82 (0.00) 1.05 (0.00) 1.46 (0.02) 2.72 (0.06) 0.90 (0.00)
Women 0.66 (0.00) 0.83 (0.00) 1.17 (0.01) 3.18 (0.28) 0.76 (0.00)
Age years
35–44 0.77 (0.00) 0.93 (0.00) 1.24 (0.03) 2.78 (0.08) 0.82 (0.00)
44–54 0.76 (0.00) 0.90 (0.00) 1.26 (0.03) 2.73 (0.10) 0.83 (0.00)
55–64 0.75 (0.00) 0.90 (0.00) 1.18 (0.02) 3.30 (0.45) 0.85 (0.00)
65–74 0.75 (0.01) 0.90 (0.01) 1.20 (0.03) 2.80 (0.18) 0.89 (0.01)
Urbanization
Urban 0.78 (0.00) 0.92 (0.00) 1.26 (0.02) 2.83 (0.09) 0.86 (0.00)
Rural 0.76 (0.00) 0.91 (0.00) 1.22 (0.02) 2.74 (0.10) 0.83 (0.00)
Region
North 0.76 (0.00) 0.90 (0.00) 1.21 (0.02) 3.63 (0.61) 0.81 (0.00)
South 0.76 (0.00) 0.92 (0.00) 1.24 (0.02) 2.80 (0.07) 0.85 (0.00)
GFR mL/min/1.73m2 Mean (SE)
Total 105.73 (0.21) 79.29 (0.11) 53.36 (0.51) 24.03 (1.23) 94.10 (0.18)
Sex
Men 107.44 (0.29) 80.20 (0.19) 54.60 (0.67) 26.87 (0.55) 98.83 (0.27)
Women 103.05 (0.26) 78.73 (0.15) 53.07 (0.58) 17.38 (0.99) 89.12 (0.23)
Age years
35–44 107.91 (0.30) 80.39 (0.20) 54.22 (0.95) 26.84 (1.02) 100.00 (0.30)
44–54 105.82 (0.42) 79.78 (0.21) 51.97 (1.06) 23.06 (3.39) 94.73 (0.38)
55–64 103.95 (0.44) 77.99 (0.24) 53.74 (0.69) 20.53 (2.22) 88.87 (0.41)
65–74 101.45 (0.66) 76.65 (0.33) 53.55 (0.72) 22.79 (2.85) 82.12 (0.54)
Urbanization
Urban 103.01 (0.26) 79.81 (0.12) 52.61 (0.75) 25.46 (0.61) 90.07 (0.20)
Rural 106.28 (0.24) 79.10 (0.15) 53.59 (0.58) 22.92 (2.74) 95.14 (0.22)
Region
North 106.56 (0.28) 79.51 (0.17) 53.16 (0.76) 17.12 (2.88) 96.04 (0.28)
South 106.01 (0.30) 78.54 (0.16) 53.46 (0.51) 23.35 (1.97) 92.68 (0.26)
GFR (mL/min/1.73m2) estimated using the simplified MDRD Study equation.
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Fig. 4. Age-standardized prevalence of
chronic kidney disease (GFR <60 mL/min/
1.73 m2) by the status of diabetes and hyper-
tension, 2000 to 2001. GFR (mL/min/1.73m2)
was estimated using the simplified MDRD
Study equation.
in CKD prevalence are consistent with data from the U.S.
population, in which GFR was also estimated using the
same equation [2]. Another limitation of our study was
that urinary protein was not measured and persons with
albuminuria or microalbuminuria were not included in
the estimated prevalence of CKD. Therefore, our find-
ings certainly underestimate the prevalence of CKD in
the Chinese adult population.
The GFR values estimated by the Cockcroft-Gault for-
mula were much lower than those estimated by the sim-
plified MDRD Study equation in our study population.
Similarly, GFR was underestimated by the Cockcroft-
Gault formula in the African-American Study of Hyper-
tension and Kidney Disease (AASK) participants [23].
In contrast, the MDRD and Cockcroft-Gault formulas
provided similar GFR estimates in the NHANES III
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study population [2]. Levey et al reported that using the
MDRD Study equation to estimate GFR was more ac-
curate than either measuring creatinine clearance or us-
ing the Cockcroft-Gault equation among patients with
moderately or severely decreased kidney function [24].
The validity of the MDRD Study equation and the
Crockcroft-Gault equation for assessing kidney function
in the Chinese population needs to be further evaluated.
Data from the U.S. NHANES III indicated that the
prevalence of moderate and severe CKD (estimated
GFR <60 mL/min/1.73m2) was 4.7% in the U.S. adult
population aged 20 years or older, representing 8.3 mil-
lion CKD patients [2]. Our study only included Chinese
adults aged 35 to 74 years. Therefore, our results are not
directly comparable with NHANES III, which included
a wider age range. Keeping these cautions in mind, the
prevalence of moderate and severe CKD was lower in
China compared to the U.S., but the actual number of pa-
tients with CKD was much greater. If applying our esti-
mates to the full Chinese adult population aged 20 years
or older, the absolute burden of CKD should be even
higher. The reasons for a substantially lower prevalence
of CKD in the Chinese population compared to the U.S.
population are not fully understood. A lower prevalence
of diabetes in Chinese population than the U.S. popula-
tion might partially explain this difference [25].
Our study shows that the burden of CKD in China is
lower in men than in women, and in younger than in older
individuals. The reasons for a higher prevalence of CKD
in women are not clear. The prevalence of ESRD was
higher in men compared to women in the U.S. and China
[1, 26, 27]. According to data from the China Registra-
tion of Dialysis and Transplantation program, the ratio
of men to women among dialysis patients in Beijing was
1.2:1 in 1999 [26]. Zheng et al reported that the ratio
of men to women was 1.3:1 among 10,002 CKD patients
with renal biopsy in China [27]. The potential explanation
for a higher prevalence of CKD but lower prevalence of
ESRD in women might be due to a slower progression
of kidney disease in women. An alternative explanation
might be that the simplified MDRD Study equation un-
derestimated GFR in women. Some investigators have
suggested that the MDRD Study equation might not per-
form well in the general population because the formula
was developed among patients with CKD [28–31].
The prevalence of CKD was significantly higher in
south compared to north China, which is consistent with
data from the China Registration of Dialysis and Trans-
plantation program, which indicated a higher prevalence
of ESRD in south compared to north China [13, 26, 32].
This finding was unexpected because the prevalence of
hypertension and diabetes has been shown to be much
higher in north than in south China [25, 33] The data
from the current study suggest that hypertension and di-
abetes increase the risk of CKD in the Chinese popula-
tion. However, there was substantial prevalence among
persons without diabetes or hypertension, possibly be-
cause of the increased importance of glomerulonephritis
as a major cause of CKD in China [13, 14]. It has been
reported that glomerulonephritis was more common in
south than in north China [13, 14].
CONCLUSION
Our study indicates that CKD is a substantial health
burden in the Chinese adult population. The actual preva-
lence of CKD in China is probably higher than reported
here because CKD patients with proteinuria and normal
or mildly decreased GFR were not included in our preva-
lence estimates. These results underscore the need to es-
tablish a national program for the detection, prevention,
and treatment of CKD aimed at reducing morbidity and
mortality from ESRD, cardiovascular disease, and pre-
mature death in China.
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